← Back to Search

Group CBT for Intolerance of Uncertainty

N/A
Waitlist Available
Led By Elizabeth Hebert, PhD
Research Sponsored by University of Manitoba
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow-up
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment for generalized anxiety disorder that targets intolerance of uncertainty. The treatment is being delivered in a group format over 12 weekly sessions.

Eligible Conditions
  • Anxiety
  • Botox

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intolerance of Uncertainty Scale
MINI International Neuropsychiatric Interview
Worry and Anxiety Questionnaire
Secondary study objectives
Depression Anxiety Stress Scales
Five Dimensional Curiosity Scale
GAD Safety Behaviours Questionnaire
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: IU Group TreatmentExperimental Treatment1 Intervention
Clinical intervention arm

Find a Location

Who is running the clinical trial?

University of ManitobaLead Sponsor
621 Previous Clinical Trials
206,543 Total Patients Enrolled
8 Trials studying Anxiety
584 Patients Enrolled for Anxiety
Elizabeth Hebert, PhDPrincipal InvestigatorUniversity of Manitoba
1 Previous Clinical Trials
1 Total Patients Enrolled
~4 spots leftby Dec 2025